Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis

Immunoglobulin light-chain (AL) amyloidosis is a rare, incurable plasma cell disorder. Its therapy has benefited immensely from the expanding drug armamentarium available for multiple myeloma. Pomalidomide in combination with weekly dexamethasone (Pom/dex) is active among patients with relapsed myel...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Dispenzieri, Angela, Buadi, Francis, Laumann, Kristina, LaPlant, Betsy, Hayman, Suzanne R., Kumar, Shaji K., Dingli, David, Zeldenrust, Steven R., Mikhael, Joseph R., Hall, Robert, Rajkumar, S. Vincent, Reeder, Craig, Fonseca, Rafael, Bergsagel, P. Lief, Stewart, A. Keith, Roy, Vivek, Witzig, Thomas E., Lust, John A., Russell, Stephen J., Gertz, Morie A., Lacy, Martha Q.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Hematology 2012
Fag:
Clinical Trials and Observations
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3369677/
https://ncbi.nlm.nih.gov/pubmed/22493299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-02-413161
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker